Healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide. $RMTI
$RMTI Board of Directors authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock. The Reverse Stock Split will take effect 12:01AM EDT July 1, 2026. https://t.co/C9gYvJMykV
$RMTI announces Q1'26 results and additional 2026 Guidance with Focus on Profitability. CC/Webcast at 8:00am ET. #earnings#ESRD#hemodialysis https://t.co/3yLavnW7F7
$RMTI to release its Q1'26 financial and operational results on Thursday, May 7, 2026. Press release at 6:00am EDT. Live conference call and webcast at 8:00am EDT. https://t.co/GJhoDXOpzt #earnings
$RMTI announces Q4/FY'25 results. Achieves Profitability on an Adjusted EBITDA basis 2nd year in a row. CC/Webcast at 8:00am ET. #earnings#ESRD#hemodialysis https://t.co/3yLavnW7F7
$RMTI to release its Q4/FY'25 financial and operational results on Thursday, March 26, 2026. Press release at 6:00am EDT. Live conference call and webcast at 8:00am EDT. https://t.co/HZU1b42MbA #earnings
Please join us in welcoming Rashad Brown as our new Vice President, Manufacturing and Supply Chain https://t.co/5rfZweFvJu #leanmanufacturing#OEE#supplychain
$RMTI to release its Q3'25 financial and operational results on Wednesday, November 12, 2025. Press release at 6:00am ET. Live conference call and webcast at 8:00am ET. https://t.co/zLVHxiqNG0 #earnings
$RMTI to release its Q2'25 financial and operational results on Thursday, August 14, 2025. Press release at 6:00am ET. Live conference call and webcast at 8:00am ET. https://t.co/Tdx9nBiB9T #earnings